Breaking News
NEWS | ICER Releases Draft Evidence Report on Treatment for Paroxysmal Nocturnal Hemoglobinuria
PHARMA NEWS | FDA Approves Iptacopan for Paroxysmal Nocturnal Hemoglobinuria
NEW WEBINAR | Empowering Patient Leaders: Understanding EU Health Policies
CLINICAL NEWS | Agios Meets Clinical Proof-of-Concept in Anaemia Treatment for Adults with Lower-Risk MDS
CASGEVY | 1st Gene-Editing Therapy for Thalassaemia and SCD Approved in UK
NEW VIDEO | Jo’s Story With β-Thalassaemia
BREAKING NEW GROUND | The First-Ever Guidelines for Managing α-Thalassaemia
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | LDH Improvements Lead to Better Outcomes in Fatigue and QoL
TIF’s NEW e-COURSE | Enhance Your Understanding of EU Health Policy
TIF2023 | 16th International Conference on Thalassaemia & Haemoglobinopathies, November 3-5
English
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic & TIF
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Loading view.
There were no results found.
There were no results found.
Events
Events
Events
Events Search and Views Navigation
Search
Enter Keyword. Search for Events by Keyword.
Find Events
Event Views Navigation
List
List
Month
Today
Upcoming
Upcoming
Select date.
Previous
Events
Today
Next
Events
Subscribe to calendar
Google Calendar
iCalendar
Outlook 365
Outlook Live
Export .ics file
Export Outlook .ics file
Back to top button
Close
Search for
